Accumulation of mitochondrial DNA damage in keratoconus corneas

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 4, 2005, Pages 1256-1263

  Atilano, Shari R ^a   Coskun, Pinar ^b,c   Chwa, Marilyn ^a   Jordan, Nicole ^a   Reddy, Vinitha ^a   Le, Khoi ^a   Wallace, Douglas C ^b,c   Kenney, M Cristina ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; RESTRICTION ENDONUCLEASE; PORIN; REACTIVE NITROGEN SPECIES;

AMPLICON; ARTICLE; CORNEA DISEASE; DNA DAMAGE; DNA ISOLATION; ENZYME SUBUNIT; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOCONUS; OXIDATIVE STRESS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; ADOLESCENT; ADULT; AGED; CHILD; CORNEA; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BLOTTING, SOUTHERN; CHILD; CORNEA; DNA DAMAGE; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KERATOCONUS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PORINS; REACTIVE NITROGEN SPECIES;

EID: 18244371958     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1395     Document Type: Article

References (63)

1. Liu E, Slomovic AR. Indications for penetrating keratoplasty in Canada, 1986-1995. Cornea. 1997;16:414-419.
2. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297-319.
3. Mamalis N, Anderson CW, Kreisler KR, et al. Changing trends in the indications for penetrating keratoplasty. Arch Ophthalmol. 1992;110:1409-1411.
4. Gondhowiardjo TD, van Haeringen NJ. Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea. 1993;12:310-314.
5. Gondhowiardjo TD, van Haeringen NJ, Volker-Dieben HJ, et al. Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea. 1993;12:146-154.
6. Behndig A, Karlsson K, Johansson BO, et al. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci. 2001;42:2293-2296.
7. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002;50:341-351.
8. Kenney MC, Chwa M, Atilano SR, et al. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci. 2005;46;823-832.
9. Kenney MC, Brown DJ. The cascade hypothesis of keratoconus. Contact Lens Anterior Eye 2003;26:139-149.
10. Cibis GW. Cornea. In: Cibis GW, ed. Fundamentals and Principles of Ophthalmology. San Francisco, CA: The Foundation of the American Academy of Ophthalmology, 2001:chap 11;
11. Basic and Clinical Science Course; vol 2.
12. Ambrosio G, Zweier JL, Duilio C, et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem. 1993;268:18532-18541.
13. Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol. 1995;27:647-653.
14. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59:527-605.
15. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J. 1980;191:421-427.
16. Salazar JJ, Van Houten B. Preferential mitochondrial DNA injury caused by glucose oxidase as a steady generator of hydrogen peroxide in human fibroblasts. Mutat Res. 1997;385:139-149.
17. Ballinger SW, Van Houten B, Jin GF, et al. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp Eye Res. 1999;68:765-772.
18. Ballinger SW, Patterson C, Yan CN, et al. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res. 2000;86:960-966.
19. Brown MD, Wallace DC. Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr. 1994;26:273-289.
20. Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston: mitochondrial DNA and disease. N Engl J Med. 1995;333:638-644.
21. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482-1488.
22. Wallace DC, Brown MD, Melov S, et al. Mitochondrial biology, degenerative diseases and aging. Biofactors. 1998;7:187-190.
23. Wallace DC. Mitochondrial defects in neurodegenerative disease. Ment Retard Dev Disabil Res Rev. 2001;7:158-166.
24. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-1312.
25. Petit PX, Susin SA, Zamzami N, et al. Mitochondria and programmed cell death: back to the future. FEBS Lett. 1996;396:7-13.
26. Richter C. Oxidative Stress, mitochondria, and apoptosis. Restor Neurol Neurosci. 1998;12:59-62.
27. McCord JM. The evolution of free radicals and oxidative stress. Am J Med. 2000;108:652-659.
28. Datta K, Sinha S, Chattopadhyay P. Reactive oxygen species in health and disease. Natl Med J India. 2000;13:304-310.
29. Good PF, Werner P, Hsu A, et al. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol. 1996;149:21-28.
30. Phillips CI, Gosden CM. Leber's hereditary optic neuropathy and Kearns-Sayre syndrome: mitochondrial DNA mutations. Surv Ophthalmol. 1991;35:463-472.
31. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr2E 1994;26:241-250.
32. Brown MD, Voljavec AS, Lott MT, et al. Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases. FASEB J. 1992;6:2791-2799.
33. Jessie BC, Sun CQ, Irons HR, et al. Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp Gerontol. 2001;37:169-174.
34. Rodriguez-Santiago B, Casademont J, Nunes V. Is mitochondrial DNA depletion involved in Alzheimer's disease? Eur J Hum Genet. 2001;9:279-285.
35. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA. 2004;101:10726-10731.
36. Murdock DG, Christacos NC, Wallace DC. The age-related accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method. Nucleic Acids Res. 2000;28:4350-4355.
37. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res. 1995;23:4122-4126.
38. Melov S, Hinerfeld D, Esposito L, Wallace DC. Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Res. 1997;25:974-982.
39. Brown DJ, Lin B, Chwa M, et al. Elements of the nitric oxide pathway can degrade TIMP-1 and increase gelatinase activity. Mol Vis. 2004;10:281-288.
40. User Bulletin 2. Foster City, CA: Applied Biosystems; 2001.
41. Critical Factors for Successful Real-Time PCR. Valencia, CA: Qiagen, Inc.; 2004.
42. Kenney MC, Nesburn AB, Burgeson RE, et al. Abnormalities of the extracellular matrix in keratoconus corneas. Cornea. 1997;16:345-351.
43. Pesce V, Cormio A, Fracasso F, et al. Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle. Free Radic Biol Med. 2001;30:1223-1233.
44. Melov S, Coskun P, Patel M, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA. 1999;96:846-851.
45. Druzhyna N, Nair RG, LeDoux SP, Wilson GL. Defective repair of oxidative damage in mitochondrial DNA in Down's syndrome. Mutat Res. 1998;409:81-89.
46. Arbuzova S, Hutchin T, Cuckle H. Mitochondrial dysfunction and Down's syndrome. Bioessays. 2002;24:681-684.
47. Busciglio J, Pelsman A, Wong C, et al. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron. 2002;33:677-688.
48. Winkler-Stuck K, Wiedemann FR, Wallesch CW, Kunz WS. Effect of coenzyme Q10 on the mitochondrial function of skin flbroblasts from Parkinson patients. J Neurol Sci. 2004;220:41-48.
49. Shen J, Cookson MR. Mitochondria and dopamine; new insights into recessive parkinsonism. Neuron. 2004;43:301-304.
50. Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995;378:776-779.
51. Yoo BC, Fountoulakis M, Cairns N, Lubec G. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. Electrophoresis. 2001;22:172-179.
52. Ogawa O, Perry G, Smith MA. The "Down's" side of mitochondria. Dev Cell. 2002;2:255-256.
53. Kim JH, Hwang JM, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye. 2002;16:710-7l4.
54. van Splunder J, Stilma JS, Bernsen RM, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology. 2004;111:1457-1463.
55. Haugen OH, Hovding G, Eide GE. Biometric measurements of the eyes in teenagers and young adults with Down syndrome. Acta Ophthalmol Scand. 2001;79:616-625.
56. Wong V, Ho D. Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children. Pediatr Neurol. 1997;16:311-314.
57. Michikawa Y, Mazzucchelli F, Bresolin N, et al. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999;286:774-779.
58. Kim WJ, Rabinowitz YS, Meisler DM, Wilson SE. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999;69:475-481.
59. Melton T, Peterson R, Redd AJ, et al. Polynesian genetic affinities with Southeast Asian populations as identified by mtDNA analysis. Am J Hum Genet. 1995;57:403-414.
60. Lum JK, Rickards O, Ching C, Cann RL. Polynesian mitochondrial DNAs reveal three deep maternal lineage clusters. Hum Biol. 1994;66:567-590.
61. Spector A, Li D, Ma W, et al. Differential amplification of gene expression in lens cell lines conditioned to survive peroxide stress. Invest Ophthalmol Vis Sci. 2002;43:3251-3264.
62. Yamada M, Hashinaka K, Inazawa J, Abe T. Expression of catalase and myeloperoxidase genes in hydrogen peroxide-resistant HL-60 cells. DNA Cell Biol. 1991;10:735-742.
63. Lin F, Jackson VE, Girotti AW. Amplification and hyperexpression of the catalase gene in selenoperoxidase-deficient leukemia cells. Arch Biochem Biophys. 1995;317:7-18.